Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis I Spuls

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
JMIR Research Protocols|September 13, 2015
Treatment of Basal Cell Carcinoma Using a One-Stop-Shop With Reflectance Confocal Microscopy: Study Design and Protocol of a Randomized Controlled Multicenter TrialDaniel J Kadouch, Albert Wolkerstorfer, Yannick Elshot, et al.
The Journal of Dermatology|May 20, 2021
Work ability and quality of working life in atopic dermatitis patients treated with dupilumabAngela L Bosma, Wouter Ouwerkerk, Merve Günal, et al.
Journal of the American Academy of Dermatology|January 12, 2020
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Journal of Vascular Surgery|October 4, 2021
Clinical characteristics associated with pain in patients with peripheral vascular malformationsMerel L E Stor, Max M Lokhorst, Sophie E R Horbach, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
The British Journal of Dermatology|May 7, 2025
Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitisAaron M Drucker, Chantel Walwyn, Cherry Chu, et al.
Journal of Travel Medicine|December 8, 2022
Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trialHannah M Garcia Garrido, Bridget van Put, Sanne Terryn, et al.
JAMA Dermatology|May 22, 2024
Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus StatementMichael E Jacobson, Yael A Leshem, Christian Apfelbacher, et al.
JAMA Dermatology|March 16, 2022
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysisAaron M Drucker, Deanna E Morra, David Prieto-Merino, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
JMIR Research Protocols|September 13, 2015
Treatment of Basal Cell Carcinoma Using a One-Stop-Shop With Reflectance Confocal Microscopy: Study Design and Protocol of a Randomized Controlled Multicenter TrialDaniel J Kadouch, Albert Wolkerstorfer, Yannick Elshot, et al.
The Journal of Dermatology|May 20, 2021
Work ability and quality of working life in atopic dermatitis patients treated with dupilumabAngela L Bosma, Wouter Ouwerkerk, Merve Günal, et al.
Journal of the American Academy of Dermatology|January 12, 2020
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiativeYael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Journal of Vascular Surgery|October 4, 2021
Clinical characteristics associated with pain in patients with peripheral vascular malformationsMerel L E Stor, Max M Lokhorst, Sophie E R Horbach, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
The British Journal of Dermatology|May 7, 2025
Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitisAaron M Drucker, Chantel Walwyn, Cherry Chu, et al.
Journal of Travel Medicine|December 8, 2022
Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trialHannah M Garcia Garrido, Bridget van Put, Sanne Terryn, et al.
JAMA Dermatology|May 22, 2024
Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus StatementMichael E Jacobson, Yael A Leshem, Christian Apfelbacher, et al.
JAMA Dermatology|March 16, 2022
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysisAaron M Drucker, Deanna E Morra, David Prieto-Merino, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Pageof 13